Revolution Capital Lease Obligations from 2010 to 2024
| RVMDW Stock | 0.33 0.01 3.09% |
Capital Lease Obligations | First Reported 2010-12-31 | Previous Quarter 87.9 M | Current Value 55.4 M | Quarterly Volatility 31.7 M |
Check Revolution Medicines, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Revolution Medicines,'s main balance sheet or income statement drivers, such as Net Interest Income of 49.5 M, Interest Income of 49.9 M or Interest Expense of 287.9 K, as well as many indicators such as Price To Sales Ratio of 294, Dividend Yield of 0.0 or PTB Ratio of 1.69. Revolution financial statements analysis is a perfect complement when working with Revolution Medicines, Valuation or Volatility modules.
Revolution | Capital Lease Obligations |
Latest Revolution Medicines,'s Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of Revolution Medicines, Warrant over the last few years. Revolution Medicines, capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Revolution Medicines, asset purchases. For example, Revolution Medicines, can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Revolution Medicines, control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Revolution Medicines,'s Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Revolution Medicines,'s overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
Revolution Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 20,568,131 | |
| Geometric Mean | 1,200,049 | |
| Coefficient Of Variation | 154.20 | |
| Mean Deviation | 27,194,841 | |
| Median | 172,000 | |
| Standard Deviation | 31,715,455 | |
| Sample Variance | 1005.9T | |
| Range | 87.8M | |
| R-Value | 0.80 | |
| Mean Square Error | 383.1T | |
| R-Squared | 0.65 | |
| Significance | 0.0003 | |
| Slope | 5,701,445 | |
| Total Sum of Squares | 14082.2T |
Revolution Capital Lease Obligations History
About Revolution Medicines, Financial Statements
Revolution Medicines, investors use historical fundamental indicators, such as Revolution Medicines,'s Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Revolution Medicines,. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 87.9 M | 55.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Revolution Stock Analysis
When running Revolution Medicines,'s price analysis, check to measure Revolution Medicines,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revolution Medicines, is operating at the current time. Most of Revolution Medicines,'s value examination focuses on studying past and present price action to predict the probability of Revolution Medicines,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revolution Medicines,'s price. Additionally, you may evaluate how the addition of Revolution Medicines, to your portfolios can decrease your overall portfolio volatility.